Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses
A commercially available immunoglobulin G (IgG) from horses, hyperimmunized to Ebola virus, was evaluated for its ability to protect cynomolgus monkeys against disease following i.m. inoculation with 1000 PFU Ebola virus (Zaire ’95 strain). Six monkeys were treated immediately after infection by i.m. injection of 6.0 ml IgG; these animals developed passive ELISA titers of 1:160 to 1:320 to Ebola, two days after inoculation. However, the beneficial effects of IgG treatment were limited to a delay in onset of viremia and clinical signs, in comparison with untreated controls. The six IgG recipients had no detectable viremia day 5, in contrast with three virus infected controls whose viremias exceeded 7.0log10 PFU/ml that day. The controls died on days 6,6, and 7, while two IgG recipients died day 7 and the remaining 4 died day 8, all with high viremias. These results document that passively acquired antibody can have a beneficial effect in reducing the viral burden in Ebola-infected primates; however, effective treatment of human patients may require antibodies with higher specific activities and more favorable pharmacokinetic properties than the presently available equine IgG.
KeywordsCynomolgus Monkey Haemorrhagic Fever Passive Immunization Lassa Fever High Viremia
Unable to display preview. Download preview PDF.
- 1.Bowen ETW, Lloyd G, Platt G, Mcardell LB, Webb PA, Simpson DIH (1978) Virological studies on a case of Ebola virus infection in man and monkeys. In: Pattyn SR (ed) Ebola virus haemorrhagic fever. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 95–100Google Scholar
- 2.Centers for Disease Control and Prevention (1995) Outbreak of Ebola viral haemorrhagic fever-Zaire, 1995. MMWR 44: 381–2Google Scholar
- 3.Centers for Disease Control and Prevention (1995) Update: Outbreak of Ebola viral haemorrhagic fever-Zaire, 1995. MMWR 44: 468–475Google Scholar
- 4.Jahrling PB (1995) Filoviruses and arenaviruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 6th ed. ASM Press, Washington, pp 1068–1081Google Scholar
- 6.Johnson KM, Webb PA, Heymann HL (1978) Evaluation of the plasmapheresis program in Zaire. In: Pattyn SR (ed) Ebola virus haemorrhagic fever. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 219–222Google Scholar
- 7.Krasnyanskii VP, Mikhailov VV, Borisevich IV, Gradoboev VN, Evseev AA, Pshenichnov VA (1994) Preparation of hyperimmune horse serum to Ebola virus. (1994) Vopr Virus 2: 91–92Google Scholar
- 8.Ksiazek TG (1991) Laboratory diagnosis of filovirus infections in nonhuman primates. Lab Anim 20: 34–46Google Scholar
- 11.Mikhailov VV, Borisevich IV, Chernikova NK, Potryvaeva NV, Krasnyanskii VP (1994) An evaluation of the possibility of Ebola fever specific prophylaxis in baboons (Papio hamadryas). Vopr Virus 2: 82–84Google Scholar